How many clinical trials are tracked for Insomnia?

199 trials are tracked, 15 with published results.

Mode

All Oncology Infectious Disease Neurology Cardiology Psychiatry Diabetes & Endocrinology Pediatrics Allergy & Immunology Rheumatology Primary Care & Family Medicine Gastroenterology Nutrition & Obesity Medicine Orthopedics & Sports Medicine OB/GYN & Women's Health Radiology & Imaging Anesthesiology & Pain Medicine Genetics & Precision Medicine Pulmonology & Critical Care Physical Medicine & Rehab Urology Nephrology Emergency Medicine Ophthalmology Dermatology Hematology Geriatrics & Aging ENT (Otolaryngology) Palliative Care

Research

Clinical Trials Drug Pipeline Weekly Digests

Reference

Conditions Medications

Community

Questions

Text Size

Log in / Sign up

Insomnia

Part of Sleep Disorders, Intrinsic

Subtypes of Insomnia

Clinical insomnia 1

55 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Insomnia

199 trials tracked for Insomnia: 61 in phase 3 or 4 and 15 with published results. The most-cited published study has 256 citations.

199Trials tracked

61Phase 3 & 4

0Recruiting

15With published results

Phase distribution

Phase 4 31 Phase 3 30 Phase 2 20 Phase 1 9 Other / NA 109

Phase 3 Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects With Insomnia Disorder Completed · 256 cited
Phase 3 Study to Assess the Efficacy and Safety of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep Completed · 252 cited
Phase 4 Reducing Suicidal Ideation Through Insomnia Treatment Completed · 157 cited
Phase 3 Comparing Internet and In-Person Brief Cognitive Behavioral Therapy of Insomnia Completed · 112 cited
Phase 3 Study to Assess the Long Term Safety and Tolerability of ACT-541468 (Daridorexant) in Adult and Elderly Subjects Suffering From Difficulties to Sleep Completed · 107 cited
Phase 3 The Healthy Patterns Sleep Study Completed · 70 cited

Show 44 more trials

Phase 4 Suvorexant and Trauma Related Insomnia Completed · 33 cited
Phase 3 Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis Completed · 24 cited
Phase 4 Efficacy of Suvorexant in the Treatment of Hot Flash-associated Insomnia Completed · 23 cited
Phase 3 Long-term Study of Lemborexant in Insomnia Disorder (SUNRISE 2) Completed · 17 cited
Phase 3 Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1) Completed · 15 cited
Phase 4 Treatment of Insomnia in Migraineurs Completed · 13 cited
Phase 4 Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs Completed · 10 cited
Phase 4 Suvorexant and Sleep/Delirium in ICU Patients Completed · 10 cited
Phase 4 Efficacy of Suvorexant in Patients With Effectively Treated Restless Legs Syndrome and Persistent Chronic Insomnia Completed · 5 cited
Phase 4 The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy Completed
Phase 4 To Compare the Effectiveness of Suvorexant vs Placebo on Sleep Pressure in Hypertensives With Insomnia Completed
Phase 4 Eszopiclone in the Treatment of Insomnia and Fibromyalgia Completed
Phase 4 Pimavanserin for Insomnia In Veterans With Posttraumatic Stress Disorder Completed
Phase 4 Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder Completed
Phase 4 Suvorexant on Sleep Disturbance in Patients With Chronic Insomnia and Suboptimally Controlled Type 2 Diabetes Completed
Phase 4 Safety and Efficacy of Chronic Hypnotic Use 2 Completed
Phase 4 A Pilot Study of Suvorexant for Insomnia in Parkinson Disease Completed
Phase 4 A Study of Suvorexant in Patients With Multiple Sclerosis Fatigue and Insomnia Completed
Phase 4 CBT-I or Zolpidem/Trazodone for Insomnia Completed
Phase 4 A Study to Find Out if Daridorexant is Safe and Efficacious in Patients With Insomnia and Comorbid Nocturia Completed
Phase 4 Partial Reinforcement II: Three Approaches to Maintenance Therapy for Chronic Insomnia Completed
Phase 4 Treating Insomnia and Improving Metabolic Health in Midlife Women With Insomnia Completed
Phase 4 A Long-Term Safety and Efficacy Study of Eszopiclone in Elderly With Primary Chronic Insomnia Completed
Phase 4 Treatment of Insomnia and Glucose Metabolism Completed
Phase 4 Efficacy and Safety of Temazepam in HIV Seropositive Patients With Insomnia Completed
Phase 4 Long Term Treatment With Zolpidem: Nightly and Intermittent Dosing Completed
Phase 4 The Effects of Eszopiclone and Lexapro on Prefrontal Glutamate and GABA in Depression With Anxiety and Insomnia Completed
Phase 4 Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia Completed
Phase 4 Mechanisms of Sleep Latency and Health: The Effect of a Melatonin Receptor Agonist in Inflammation and Insulin Resistance Completed
Phase 4 The Treatment of Insomnia in Patients With HIV Disease Completed
Phase 4 Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia Completed
Phase 4 Eszopiclone Treatment & Cortisol Responsivity Completed
Phase 4 Study of the Insomnia in Patients With Low Back Pain Completed
Phase 3 Two Contrasting Interventions for Sleep Management Completed
Phase 3 Treatment of Insomnia in Elderly Sleep Apnea Patients With Ramelteon (TAK 375) Completed
Phase 3 A Study to Evaluate Next-Dose Transition From Zolpidem to Lemborexant (LEM) for the Treatment of Insomnia Completed
Phase 3 Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study B (MK-4305-029) Completed
Phase 3 Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia Completed
Phase 3 Safety and Efficacy Study of Suvorexant in Participants With Primary Insomnia - Study A (MK-4305-028) Completed
Phase 3 VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia Completed
Phase 3 Efficacy and Safety Study of Org 50081 (Esmirtazapine) in Elderly Participants (P05709) Completed
Phase 3 A Six Week, Double-Blind Randomized, Efficacy and Safety, Sleep Lab Trial With Esmirtazapine (Org 50081) (P05707) Completed
Phase 3 Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients Completed
Phase 3 A Phase III Study of Eszopiclone in Patients With Insomnia (Study SEP 190-150) Completed

Showing the 50 most-cited and recently-updated of 199 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

‹ Prev 1 2 3 4 5 Next ›

Questions about Insomnia

Can breathwork reduce stress and anxiety in paramedic students with insomnia?

Yes, a 12-week RCT found that slow diaphragmatic breathwork significantly reduced stress, anxiety, and insomnia in paramedic students.

Full answer →